New Bruker-Biognosys collaboration aims to deliver advanced proteomics CRO services

Close up of chemical microscope and medical research equipment in scientific laboratory. Liquid examination tool with glass lens and blood samples in vacutainers on professional desk

Bruker Corporation and Switzerland-based Biognosys AG today announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed. J.P.Morgan acted as exclusive financial advisor to Biognosys.

Get lifetime access to 10TB of cloud storage for under £80

Previous article

Elucidating enzyme gene expression in filamentous fungi for efficient biomass energy production

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News